Print

Purpose

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients (18 years or more), female or male - Histologically confirmed diagnosis of extra-CNS primary solid cancer - Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria - Performance status compatible with enrolment into clinical trials - Ability to consent - Signed informed consent form from patient - Participation in a parallel clinical trial is allowed in this non-interventional study

Exclusion Criteria

  • Inability to give informed consent - Inability to adhere to recommended follow-up according to the treating physician Vulnerable participants will not be included.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

MD Anderson Cancer Center
Houston, Texas 77030
Contact:
Barbara O'Brien
832-837-9347
BJOBrien@mdanderson.org

More Details

Status
Recruiting
Sponsor
University of Zurich

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.